Dysregulation of genetic pathways during human germ cell development leads to infertility. Here, we analysed bona fide human primordial germ cells (hPGCs) to probe the developmental genetics of human germ cell specification and differentiation. We examined the distribution of OCT4 occupancy in hPGCs relative to human embryonic stem cells (hESCs). We demonstrated that development, from pluripotent stem cells to germ cells, is driven by switching partners with OCT4 from SOX2 to PAX5 and PRDM1. Gain-and loss-of-function studies revealed that PAX5 encodes a critical regulator of hPGC development. Moreover, an epistasis analysis indicated that PAX5 acts upstream of OCT4 and PRDM1. The PAX5-OCT4-PRDM1 proteins form a core transcriptional network that activates germline and represses somatic programmes during human germ cell differentiation. These findings illustrate the power of combined genome editing, cell differentiation and engraftment for probing human developmental genetics that have historically been difficult to study.
S
ubstantial research has centred on the identification and characterization of genes that are required for the specification, maintenance and differentiation of the mammalian PGCs that ultimately give rise to the sperm and eggs required to perpetuate life [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . In mice, several transcription factors have been identified that are required for the in vitro specification and induction of the earliest stages of germ cells. These germ cells are ultimately able to mature and fulfil the greatest test of germ cell identity, the ability to produce live offspring 10, [14] [15] [16] [17] [18] . However, the transcriptional network of hPGCs differs substantially from that of mice, making it difficult to translate this knowledge directly to humans 11 . For example, hPGCs express lineage specifier genes, such as SOX17, that are not expressed in mouse PGCs 19 . Although hPGCs are committed to the germ cell lineage, they share with hESCs expression profiles of several pluripotency genes, including OCT4 (also known as POU5F1); however, other key pluripotency genes, such as SOX2, are not expressed in hPGCs 11, 20, 21 . How the network of pluripotency genes, which encode transcription factors, functions differently in hESCs and hPGCs is a fundamental question in the field of human germ cell developmental genetics that has remained unaddressed. Thus, in this study, we elucidated genetic mechanisms that underlie the development of hPGCs by identifying transcription factors that might function in a network to mediate hPGC specification and differentiation. We focused on OCT4, an essential gene that encodes a transcription factor that is expressed in both hESCs and hPGCs and is required to maintain cell identity in both cell types [22] [23] [24] . We developed methods to map the genome-wide binding of the OCT4 protein in highly heterogeneous tissue samples and identified OCT4 protein partners in hPGCs. We then used gain-and loss-of-function gene analyses to probe the function of PAX5, a member of the paired box (PAX) family, and discovered that it encodes a critical component of a genetic switch that is required for the transition from pluripotent stem cells to the differentiation of hPGCs.
Results
Global redistribution of OCT4 occupancy in the transition from hPSCs to hPGCs. To probe the role of OCT4 in hPGCs, we performed OCT4 chromatin immunoprecipitation (ChIP) assays with sequencing (ChIP-seq) on germ cells from second trimester human fetal testis cells. At this developmental stage, hPGCs have colonized the testis and are in the process of expanding to approximately 1-2 million cells in total, but have not differentiated to spermatogonia or spermatocytes 6 . We noted that OCT4-positive cells are only present in the seminiferous tubules of the testis and not within the interstitial spaces (Fig. 1a, Supplementary Fig. 1a ). Immunostaining data also indicated that OCT4-positive cells are a subpopulation of c-KIT-positive cells and do not express DDX4, which is an evolutionarily conserved germ cell marker of later stages of development (post-PGC; Supplementary Fig. 1b,c) . However, since only 1% of the cells in the human fetal testis are OCT4-positive hPGCs (Fig.1a, Supplementary Fig. 1a ), and conventional ChIP protocols require a large number of homogenous cells, we adapted protocols from carrier ChIP 25 and tissue ChIP 26 to detect binding specificities of individual transcription factors within a heterogeneous cell mixture. We validated our protocol using a heterogeneous control mixture of 10,000 OCT4-positive hESCs mixed with 990,000 OCT4-negative fibroblast cells to model the composition of fetal testis ( Supplementary Fig. 1d ). We compared these data to that generated by conventional ChIP on a pure population of 1 million hESCs by quantitative PCR (qPCR; Supplementary Fig. 1e ) and ChIP-seq. We found that the result from mixed-ChIP correlated highly with Articles NATuRE CEll BIOlOGy that from conventional ChIP ( Supplementary Fig. 1f-h ). Thus, our methods are reliable for generating binding data from a heterogeneous mixture of cells when coupled with highly specific antibodies.
We then applied the mixed-ChIP protocol to human fetal testis samples and generated a global binding profile for OCT4 in bona fide hPGCs. Two biological replicates were used and these replicates demonstrated a gene overlap of > 90% (Supplementary Fig. 1h ).
Although the enrichment profile of OCT4 around the transcription start sites was similar in both hPGCs and hESCs (Fig. 1b) , there was a substantial redistribution of OCT4 binding. This redistribution was characterized by reduced binding near pluripotency-related genes (for example, OCT4, NANOG and LIN28A) and an enrichment of binding near germ cell-related genes (for example, PIWIL1, DDX4 and NANOS2) in hPGCs relative to hESCs (Fig. 1c,d ). Furthermore, Articles NATuRE CEll BIOlOGy a gene ontology (GO) analysis of genes bound by OCT4 only in hPGCs revealed that genes were enriched in GO terms that include male gamete generation and spermatogenesis, while genes bound by OCT4 in both hESCs and hPGCs were enriched in neuronal development. This result suggests that OCT4 may repress ectoderm differentiation in both cell types (Fig. 1e) . Together, our data demonstrated that the cell fate change from pluripotent hESCs to bona fide germline hPGCs is associated with a global reorganization of OCT4 occupancy.
OCT4 switches partners to PAX5 and PRDM1 in hPGCs. We next set out to determine whether the genomic redistribution of OCT4 could be due to alternative OCT4 binding partners in hPGCs relative to hESCs. Immunostaining and RNA expression data showed that the expression of SOX2, OTX2 and ZIC2, genes that encode well-characterized functional partners of OCT4 in hESCs [27] [28] [29] [30] , are significantly downregulated in hPGCs 31 ( Supplementary Fig. 2a,b ). This result indicated that OCT4 might require different partners in hPGCs compared with in hESCs. To screen for potential OCT4-interacting transcription factors in hPGCs, we performed de novo sequence motif searches using OCT4-bound sequences exclusively in hPGCs and discovered motifs that are similar to consensus motifs for the transcription factors PAX5 and PRDM1 (Fig. 2a) . Immunostaining demonstrated extensive co-expression of PAX5 and PRDM1 in OCT4-positive cells (Fig. 2b) . Quantitation indicated that approximately 60% of the OCT4-positive cells are also positive for PAX5 and PRDM1. A RNA expression analysis also showed significant induction of PAX5 and PRDM1 in hPGCs compared with hESCs 31 ( Supplementary Fig. 2b ). This result suggested that PAX5 and PRDM1 might co-occupy genomic loci with OCT4 as functional complexes in a germ cell-specific transcriptional network.
To determine the binding profiles of PAX5 and PRDM1 and to probe the potential association with OCT4 in hPGCs, we performed a ChIP-seq analysis for both PAX5 and PRDM1 ( Supplementary  Fig. 2c ). Among the top 5,000 genes bound by each transcription factor, 1,441 genes, including germ cell-specific genes (for example, DDX4, DAZL and PIWIL1) were collectively bound by all three transcription factors (Fig. 2c,d ). These results suggested extensive co-occupancy of PAX5, PRDM1 and OCT4 in hPGCs. An annotation analysis revealed that these co-bound genes are enriched for GO terms of germ cell signalling, hESC pluripotency and bone morphogenetic protein (BMP) signalling pathways (Fig. 2e) . In addition, we observed that a recombinant OCT4-GST (glutathione S-transferase) fusion protein can immunoprecipitate recombinant PAX5 protein in vitro (Fig. 2f) , indicating that PAX5 may interact directly with OCT4 protein in hPGCs. We did not detect direct protein interactions between recombinant OCT4 and PRDM1 proteins. However, PRDM1 protein was pulled down by PAX5 and vice versa ( Supplementary Fig. 2d ), indicating that OCT4, PAX5 and PRDM1 may assemble as a protein complex through both direct and indirect interactions. In summary, our observations suggested that OCT4, partnering with PAX5 and PRDM1 proteins, might constitute an extensive and unique transcription network in hPGCs.
Overexpression of PAX5 and PRDM1 induces human germ cell differentiation. Although PRDM1 is a well-studied key regulator of PGC development in both mice and humans 15, 19, 32 , the discovery of PRDM1 as a binding partner of OCT4 has not been previously shown. Additionally, although PAX5 is most commonly known for its role in development of the blood system 33 , a potential role for PAX5 in PGC development or specification has not yet been reported. To investigate the roles of both genes in hPGCs, we examined whether overexpression of PAX5 and PRDM1 is capable of directing hESCs to the germ cell lineage in an in vitro differentiation system. We overexpressed PAX5 or PRDM1 by approximately 10-15 times above the endogenous expression levels ( Supplementary Fig. 3a) to a level comparable to that of bona fide hPGCs ( Supplementary  Fig. 2b ). Forced expression of either PAX5 or PRDM1 did not alter the identity of ESCs in routine hESC maintenance ( Supplementary  Fig. 3b,c) . Next, we differentiated hESCs overexpressing PAX5 or PRDM1 by exposing the cells to BMPs for 7 days, as previously described 5, 34 . The expression of germ cell marker genes, including DAZL, DDX4, DPPA3 and NANOS3, was significantly upregulated in cells overexpressing these factors compared with control cells (Fig. 3a, Supplementary Fig. 3d ). PAX5 also demonstrated binding on several later stage germ cells genes, such as SYCP1 and SYCP3, and activated their expression during differentiation (Fig. 3a,  Supplementary Fig. 3e ). Interestingly, co-expression of PAX5 and PRDM1 showed no obvious additive effects relative to overexpression of either gene alone (Supplementary Fig. 3f ). Immunostaining revealed a DDX4 signal in cells overexpressing PAX5 but not control cells (Fig. 3b) . We also used a hESC-DDX4-mOrange knock-in reporter cell line to better characterize the effects of in vitro differentiation. FACS analyses revealed a significantly higher percentage of DDX4-mOrange-positive cells in the cells overexpressing PAX5 relative to control cells (Fig. 3c) . These data demonstrated that induced expression of PAX5 and PRDM1 in hESCs strongly promotes the differentiation of germ cells in vitro and prompted us to explore whether these cells may further mature if placed in the somatic niche via xenotransplantation.
To investigate the differentiation potential in vivo, we used a previously developed xenotransplantation platform [2] [3] [4] . Briefly, we transplanted green fluorescent protein (GFP)-tagged human cells into busulfan-treated immunodeficient mice, which are depleted of endogenous germ cells (Fig. 3d, Supplementary Fig. 4a ). Two months post-transplantation, we analysed the testes and observed significant human germ cell engraftment in the tubules for cells overexpressing PAX5 or PRDM1, as indicated by the presence of GFP-positive cells that co-expressed DDX4 (Fig. 3e) . More importantly, cells overexpressing PAX5 differentiated to a later stage germ cell fate and expressed mature germ cell markers, such as DAZL and DAZ1 (Fig. 3f) . To quantify germ cell potential, we counted GFP-positive and DDX4-positive human germ cells and tubules across entire cross-sections. We then calculated the percentage of positive tubules and determined the number of GFP-positive and DDX4-positive cells in each positively stained tubule. Both values were significantly higher in cells overexpressing PAX5 or PRDM1 (Fig. 3g,h ). Consistent with the in vitro differentiation results, cells overexpressing both PAX5 and PRDM1 promoted germ cell differentiation of hESCs in the mouse seminiferous tubule; however, no additive effects were detected compared with cells overexpressing each factor alone ( Supplementary Fig. 4b-d) . These data provide strong evidence that overexpression of PAX5 and PRDM1 is able to greatly promote the differentiation potential of hESCs towards the germ cell lineage in vitro and in vivo.
Knockout of PAX5 or PRDM1 reduces the germ cell potential of hESCs. We further examined the role of PAX5 in germ cell differentiation by performing loss-of-function studies. We generated a PAX5-knockout hESC line via CRISPR (clustered regularly interspaced short palindromic repeats)-Cas9-based genome editing ( Supplementary Fig. 5a ,b). Knockout of PAX5 was confirmed by immunofluorescence and western blot analyses upon induced neuronal differentiation 35, 36 ( Supplementary Fig. 5c,d ). Moreover, a significant reduction of germ cell gene expression was observed after in vitro differentiation ( Fig. 4a ) and DDX4 was not detected (Fig. 4b) , further indicating that germ cell differentiation is severely reduced in vitro. We then examined whether germ cells could be differentiated and maintained from these cell lines via in vivo xenotransplantation. Articles NATuRE CEll BIOlOGy DDX4-positive cells were mouse germ cells regenerated after treatment (Fig. 4c ). There was a greater than threefold reduction of positive tubules and a greater than fivefold reduction of GFP-positive and DDX4-positive cells in the positive tubules (Fig. 4d,e) , indicating that genetic knockout of PAX5 greatly reduced germ cell differentiation from hESCs. Previous studies have revealed that PRDM1-knockout hESCs fail to develop into PGCs in vitro 19 . To determine whether these cells are also compromised in terms of germ cell differentiation in vivo, we used previously reported PRDM1-knockout hESCs 19 to test their ability to differentiate into germ cells in murine xenotransplants. We observed that PRDM1-knockout hESCs were severely deficient in germ cell differentiation in vivo (Fig. 4f) , with the majority of tubules devoid of any human germ cell engraftment. Only a small number of tubules were observed, with sparse GFP-positive and DDX4-positive cells. Counts of the engraftment revealed a greater than tenfold reduction in the formation of human germ cells in the mouse tubules (Fig. 4g,h ), resulting in a more severe defect in germ cell potential compared with PAX5-knockout cells.
Epistasis of PAX5, OCT4 and PRDM1 in hPGCs.
To explore the molecular mechanism of PAX5 function in hPGCs, we re-analysed our ChIP-seq data and observed that the enhancers of OCT4, which are bound by OCT4 itself in hESCs, are bound by PAX5 in hPGCs (Fig. 5a) . Thus, we hypothesized that one role of PAX5 is to regulate and maintain OCT4 expression, as germ cell differentiation proceeds and requires expression of OCT4 at moderate levels 37 . We first tested this hypothesis by examining OCT4 expression during in vitro differentiation. Following BMP-induced differentiation, OCT4 expression in cells overexpressing PAX5 was substantially elevated relative to differentiated control cells (Fig. 5b) . However, due to the developmental limitation of current in vitro differentiation, genes essential for later stage germ cells (for example, DDX4 and DAZL), including PAX5, cannot be induced to the functional level 1931,38,] ( Supplementary Fig. 6a,b) . Thus, PAX5-knockout cells only exhibited a minor decrease in OCT4 expression relative to control differentiated cells for all three protocols ( Supplementary Fig. 6c ). To overcome this limitation, we sorted hPGCs that were formed in vivo in mouse seminiferous tubules via GFP and c-KIT immunostaining and analysed the effects of PAX5 knockout in vivo (Fig. 5c,d) . Note that the niche of mouse seminiferous tubules provides a superior differentiation environment for hESCs to develop to more mature hPGCs that express genes essential for later stage germ cells, including DDX4 (Fig. 3e,f) . In these in vivo-derived hPGCs, there was a significant downregulation of OCT4 expression in cells formed by PAX5-knockout cells, and, as expected, a significant upregulation of OCT4 expression in cells formed by cells overexpressing PAX5 compared with cells formed by control hESCs (Fig. 5e) .
To further determine whether PAX5 regulates OCT4 expression by regulating the enhancer of OCT4, a luciferase reporter assay was Articles NATuRE CEll BIOlOGy performed in HEK293T cells. As expected, overexpression of PAX5 caused a significant increase in luciferase activity, suggesting that PAX5 could activate OCT4 expression through its enhancer (Fig. 5f ).
We also identified the binding motif of PAX5 in the region of the OCT4 enhancer sequences ( Supplementary Fig. 7a-c) . The results indicated that a mutation in the PAX5-binding motif abolished the induction effect of the PAX5 protein ( Supplementary Fig. 7d ).
Further analysis of the ChIP-seq data indicated that PAX5 and OCT4 bind to PRDM1 enhancers with high intensity (Fig. 6a) , suggesting that PAX5 and OCT4 might act upstream of PRDM1 to regulate its expression. We found an increase of PRDM1 in hPGCs formed from cells overexpressing PAX5 and a significant decrease in hPGCs formed from PAX5-knockout cells (Fig. 6c) . The luciferase reporter assay in HEK293T cells showed that both PAX5 and OCT4 were able to significantly increase luciferase activity driven by the PRDM1 enhancer (Fig. 6d) . These results indicated that PAX5 and OCT4 could act on the PRDM1 enhancer as activators to induce PRDM1 expression, potentially during germline differentiation. A mutation in the PAX5-binding motif in the PRDM1 enhancer region abolished the induction effects of the PAX5 protein ( Supplementary Fig. 7e-h ). Since PRDM1 is a critical gene for germ cell specification and it could be downstream of PAX5 and OCT4, we overexpressed PRDM1 in PAX5-knockout cells to test whether PRDM1 could rescue the defect of PAX5-knockout cells. Indeed, we observed that overexpression of PRDM1 restored the germ cell potential of PAX5-knockout cells (Fig. 6e) .
Taken together, our data shed light on the epistasis of these three transcription factors during differentiation from hESCs to hPGCs Articles NATuRE CEll BIOlOGy (Fig. 6f) . In pluripotent stem cells, OCT4 interacts with SOX2 and other cofactors, and binds to its own enhancer to activate and maintain high expression. In contrast, during the differentiation of germ cells, PAX5 replaces OCT4, recognizes its own binding motif and binds to the enhancer of OCT4 to maintain a moderate expression of OCT4. Concurrently, PAX5 and OCT4 may bind to the enhancer 
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h E S C s P A X 5 Upon induced germ cell differentiation with BMPs, OCT4 expression is reduced to moderate levels and maintained in partnership with PAX5. To efficiently induce germline programmes, OCT4 represses ectodermal genes and, at the same time, together with PAX5, activates PRDM1 to repress mesodermal and endodermal genes. In PAX5 knockout cells, OCT4 expression has decreased to levels so low that the expression of ectodermal genes is not suppressed effectively. Thus, the efficiency of induction of germ cells is low in PAX5 knockout cells and lower in PRDM1 knockout cells. Due to the low expression of OCT4 and loss of PRDM1 function, genes in all somatic lineages are upregulated and germ cell programmes fail to be activated. e, Summary of data establishing the roles of PAX5 and PRDM1 in hPGC specification in vitro and in vivo. The identity of hESCs is maintained by a core transcriptional network centred by OCT4, SOX2 and NANOG. Induced by BMP signals in vitro or in vivo by xenotransplantation, hESCs start to differentiate to early hPGCs, which express early germ cell markers, such as OCT4, SOX17, PRDM1 and NANOS3 (grey line with arrowhead). Overexpression of PAX5 is able to enhance the efficiency to early hPGCs and promote early hPGCs to the later stage, which express mature germ cell markers, such as DDX4, DAZL and DAZ1 (black line with arrowhead). Loss of PAX5 significantly reduces the germ cell potential of hESCs (grey broke line with arrowhead), while loss of PRDM1 leads to failure of hPGC specification (red line with an end bar). Source data for a-c are provided in Supplementary Table 2 .
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Articles NATuRE CEll BIOlOGy of PRDM1 and activate its expression to initiate the germ cell programme.
Molecular model of the PAX5-OCT4-PRDM1 network.
OCT4 is known to repress ectoderm formation from hESCs 39 and during germ cell differentiation (Fig. 1e) . In addition, PRDM1 has been shown to suppress endoderm and other somatic genes during gem cell specification 19 . Thus, we wondered whether PAX5, together with OCT4 and PRDM1, might function globally during germ cell differentiation. We examined the expression of somatic genes during in vitro differentiation (Supplementary Table 1 ). We detected downregulation of somatic genes belonging to the three primary germ layers in cells overexpressing PAX5 (Fig. 7a) . In contrast, a significant upregulation of expression in ectodermal genes was observed in PAX5-knockout cells (Fig. 7b) . This result suggests that PAX5 could repress ectoderm and that the repression might be mediated through the ability of PAX5 to activate or maintain OCT4 expression. Moreover, consistent with previous studies of PRDM1 19 , we observed significant upregulation of somatic genes in all three germ layers during the differentiation of PRDM1-knockout cells (Fig. 7c) , confirming the role of this gene in suppressing the differentiation of somatic lineages during human germ cell development.
Based on our data, we propose a molecular model of human germ cell development (Fig. 7d) . Upon external signalling via factors such as BMPs, germ cell differentiation is induced under both in vitro and in vivo conditions, and OCT4 expression is reduced to a moderate level that is partly maintained by a partnership with PAX5. To efficiently induce and maintain germline programmes, OCT4 represses ectodermal genes and at the same time, together with PAX5, activates PRDM1 to repress mesodermal and endodermal genes. In PAX5-knockout cells, OCT4 expression was so low that the expression of ectodermal genes was not suppressed effectively. Thus, the efficiency of induction of germ cells is very low in PAX5-knockout cells. A more severe case is observed in PRDM1-knockout cells, in which there is an almost complete loss of expression of OCT4 and PRDM1. Moreover, genes in all somatic lineages are upregulated and the germ cell programmes fail to be activated.
Discussion
This work prompts a molecular model for germ cell development (Fig. 7e) . In hESCs, OCT4 partners with pluripotent master regulators, including SOX2, to form the core transcriptional network that governs self-renewal and pluripotency. Induced by BMP signals in vitro and in vivo, hESCs differentiate into early hPGCs with low efficiency. Induction of PAX5 expression in hESCs results in their differentiation into more mature human germ cells, with significantly higher efficiency. These later stage differentiated cells closely resemble late hPGCs or gonocytes and express genes such as DDX4, KIT and DAZL, which mark mature human germ cells. Conversely, loss of function of PAX5 results in a lower efficiency in germ cell differentiation and loss of function of PRDM1 results in a complete failure of germ cell specification. Thus, this study provides evidence that human cell fate determination, at the juncture of pluripotency and somatic and germ line differentiation, may be the result of a balance of forces. That is, the co-expression of pluripotency genes (for example, OCT4 and NANOG) simultaneously with lineage specifiers (for example, SOX17, PAX5 and PRDM1) distinguishes hPGCs from all other human cells and from mouse PGCs. To maintain cell identity, hPGCs require a precise regulation and balance of pluripotency and lineage specifiers to move forward from pluripotent stem cell while repressing somatic lineage development and activating germ cell programmes. The PAX5-OCT4-PRDM1 axis that has been identified, along with the transcription factor genome-wide binding profiles, define the identity of bona fide hPGCs at stages beyond those commonly reported in vitro. The results of these studies may shed light on genetic requirements for human germ cell differentiation, enable more faithful and efficient production of human germ cells in vitro, and contribute to knowledge and models of human germ cell pathologies.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41556-018-0094-3.
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Methods hESC culture and differentiation. H1 hESCs (WiCell) were maintained feederfree on Matrigel (BD Biosciences)-coated plates as previously described [1] [2] [3] [4] [5] . The cell line was authenticated by immunostaining for cell-type specific proteins and tested as negative for mycoplasma contamination. All cultures were grown at 37 °C with 5% CO 2 in mTeSR1 medium (Stemcell Technologies). For differentiation, cells were seeded overnight at a density of 200,000 per well in 6-well plates and medium was replaced the next day with differentiation media (knockout DMEM supplemented with 20% fetal bovine serum, 1 mM L-glutamine, 0.1 mM nonessential amino acids, 0.1 mM β -mercaptoethanol and 50 ng ml −1 recombinant human BMP4, BMP7 and BMP8b (R&D systems)) as previously described 5, 34, 40 . Differentiation medium was changed every other day for 7 days.
Xenotransplantation assay. Human cell lines were transplanted into the testes of busulfan-treated, immunodeficient nude mice (NCr nu/nu; Taconic) as previously described [1] [2] [3] [4] 41 . Immunodeficient nude mice were treated with a single dose of busulfan (40 mg kg
; Sigma-Aldrich) at 5-6 weeks of age to eliminate endogenous spermatogenesis. Xenotransplantation was then performed 5-6 weeks after busulfan treatment by injecting 7-8 μ l cell suspensions (1.5-3 million cells per testis) containing 10% trypan blue (Invitrogen) into the seminiferous tubules of each recipient testes via cannulation of the efferent ducts. At 8 weeks after transplantation, recipient mouse testes were collected for histology and immunohistochemical analyses. Procedures were evaluated and approved by the University of Pittsburgh and Montana State University Institutional Animal Care and Use Committee (IACUC); all procedures were compliant with all relevant ethical regulations regarding animal research.
ChIP on human fetal testes. Second trimester human fetal testes were staged and procured from Advanced Bioscience Resources. The ChIP protocol for human fetal testes (22 weeks) was adapted from published protocols 25, 26 and optimized as follows. The protocol for tissue procurement and use was approved by the Institutional Review Board of Montana State University (RR-P031014-EX); all procedures were compliant with all relevant ethical regulations regarding human research with unidentifiable banked tissue. The consent was obtained from all the participants. Human fetal testis samples (~25 mg for each ChIP) were placed in a 100 mm dish on ice and finely minced using a clean scalpel. Minced tissue was then transferred into a 15 ml conical tube. PBS (1 ml) with protease inhibitor cocktail (Roche) was added to the tissue. To crosslink, tissue was fixed in 1.5% formaldehyde and rocked at room temperature for 20 min, quenched with 1 volume of 250 mM glycine (room temperature, 5 min), and rinsed with chilled TBSE buffer (20 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA) twice. Crosslinked tissue was resuspended in PBS with protease inhibitor cocktail (1 ml 0.1% SDS buffer for every 100 μ l of nuclear pellet) and transferred to a Dounce homogenizer. Tissue pieces were then disaggregated into single cell suspension with 20-25 strokes. The cell suspension was transferred to a 15 ml conical tube and centrifuged at 1,000g in a bench-top centrifuge for 5 min at 4 °C. Cells were lysed with 1% SDS lysis buffer (on ice, 5 min) and then centrifuged (450g, 10 min). Supernatant was removed as described above and samples were resuspended in 0.1% SDS buffer with protease inhibitor cocktail. Samples were then sonicated with glass beads 12 times (30 s pulses with 30 s break interval) using a Bioruptor water bath sonicator (Diagenode). Chromatin extracts were then precleared with Dynal Magnetic Beads (Invitrogen) (4 °C, 1 h) followed by centrifugation (450g, 30 min). Supernatant (precleared chromatin) was immunoprecipitated overnight with Dynal Magnetic Beads coupled with the following antibodies: anti-OCT4 (sc-8628, Santa Cruz Biotechnology), anti-PAX5 (sc-1974, Santa Cruz Biotechnology), and anti-PRDM1 (C14A4, Cell Signaling Technology). On the next day, beads were washed with 0.1% SDS buffer for three times followed by a wash with TE buffer. Chromatin was eluted by incubating beads in TE buffer supplemented with 1% SDS at 65 °C for 30 min. Afterwards, chromatin underwent reverse crosslinking with pronase at 42 °C for 2 h and at 67 °C for 6 h. DNA was then purified using phenol-chloroform extraction. ChIP DNA was subjected to 15 cycles of amplification using a SeqPlex DNA Amplification kit (Sigma). Real-time qPCR (RT-qPCR) was performed (ABI PRISM 7900 Sequence Detection System), and relative occupancy values were determined based on the immunoprecipitation efficiency (amount of immunoprecipitated DNA relative to input). Illumina HiSeq 2 × 60 base-pair paired end reads were used for sequencing.
Immunofluorescence analysis for cell culture. Cells were fixed with 4% paraformaldehyde at room temperature for 20 min, permeabilized with 0.3% Triton X-100 in PBS (PBST) for 10 min, and blocked for 45 min at room temperature in PBST containing 5% normal donkey serum (Jackson ImmunoResearch Laboratories). Primary antibodies were diluted at 1:200 in blocking solution and incubated at 4 °C overnight. The following primary antibodies were used in this study: DDX4 (R&D; AF2030), OCT4 (Santa Cruz; sc-8628), PAX5 (Santa Cruz; sc-1974), PRDM1 (Cell Signaling; 9115) and c-KIT (DAKO; A4502). Appropriate Alexa Fluor 488, 594 or 647-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories) were diluted at 1: 300 in PBS containing 0.1% bovine serum albumin (BSA) and incubated at room temperature for 1 h.
For nuclear staining, 4,6-diamidino-2-phenylindole (DAPI; 1 μ g ml -1 ) was used. Images shown are representative of at least three independent experiments. RNA isolation, library preparation and sequencing analysis. Total RNA was extracted using an Acruturus PicoPure RNA Isolation kit (Life Technologies). RNA quality was determined using a Bioanalyzer 2100 (Agilent). Sequencing libraries were constructed using a SMARTer universal low input RNA kit (Clonetech) according to the manufacturer's instructions. DNA library samples were submitted to the Stanford Genomics Facility and 100-base pair-end high-throughput sequencing was performed. All sequenced libraries were mapped to the human genome using TopHat and Cufflink 42, 43 and the default parameter setup. Differential expression was analysed using StrandNGS (AvadisNGS).
Gene expression analysis by qPCR. Total RNA for qPCR was extracted from cells using a RNeasy Plus Mini kit (Qiagen) and 1 μ g RNA was reverse transcribed using the SuperScript® III First-Strand Synthesis System. qPCR was performed in triplicate using Power SYBR® Green PCR Master Mix (both from Life Technologies) with the data normalized to housekeeping genes. The primer sequences are listed in Supplementary Table 1 . Data shown are representative of at least three independent experiments.
Immunohistochemistry of recipient mouse testes. Paraformaldehyde-fixed mouse testes were sectioned by AML Laboratories by paraffin embedding and conducting serial cross-sectioning every 5 mm. For deparaffinization, two consecutive xylene (Sigma-Aldrich) treatments (each 10 -min long) were performed followed by rehydration in 100%, 100%, 90%, 80% and 70% ethanol treatments. A 10-min wash in tap water was then performed. Antigen retrieval was conducted by boiling slides for 30 min in 0.01 M sodium citrate (pH 6.0; Sigma-Aldrich), cooling slides for 30 min, followed by a 10 min wash in PBS. Blocking and permeabilization was conducted by adding 10% normal donkey serum (Jackson Immunoresearch) with 0.1% Triton X (Sigma-Aldrich) in PBS for 1 h, followed by incubation with primary antibodies diluted in 1% blocking solution overnight at 4 °C in a humidified chamber. The following antibodies were used: DDX4 (R&D; AF2030), GFP (Abcam; ab13970), OCT4 (Santa Cruz; sc-8628) and DAZL (Novus; NB100-2437). Slides were washed in PBST, followed by incubation for 1 h with fluorescently labelled secondary antibodies raised in donkey, followed by additional washes in PBST. The primary antibodies were used at 1:200 dilution and secondary antibodies were used at 1:300 dilution. All samples were mounted using ProLong Gold Anti-fade mounting media containing DAPI (Life Technologies). Samples were then imaged using a confocal microscope (Zeiss). Quantification of GFP-positive and DDX4-positive staining was determined manually from multiple sections taken from two to three different depths within the testis (technical replicates) and from multiple clonal replicates for each transplanted cell line (biological replicates).
Motif analysis. Motif analysis was performed using the MEME-ChIP suite and the default parameters. The novel motif for OCT4 in hPGCs were searched in TRANSFAC and JASPER databases to find transcription factors with similar consensus sequences 44, 45 . CRISPR design and PAX5-knockout derivation. CRISPR guide RNAs (gRNAs) were designed using the online CRISPR design tool from the Massachusetts Institute of Technology (http://crispr.mit.edu/). Candidate gRNAs with the highest score were chosen for each genomic region. Oligonucleotides for these gRNAs were synthesized and cloned into plasmid pX459 (Addgene; 48139) carrying both Cas9 and gRNA expression cassettes, with one modification of the original plasmid in which the Cas9 promoter was replaced by the EEF1A1 promoter. The cutting efficiency of each gRNA construct was validated by transfecting HEK293T cells and sequencing the target regions in the genome. CRISPR pairs were nucleofected into H1 hESCs and plated as single cells. Single cells were clonally expanded and isolated for PCR to test for successful PAX5 deletion and for sequencing.
Construction of overexpression constructs by lentiviral vectors.
The sequences of PAX5 and PRDM1 were assembled using Gibson Assembly Cloning technology (NEB). Briefly, gBlocks (gene fragments) were synthesized by Integrated DNA Technologies, and individual gBlocks were assembled to one gene transcript with Gibson Assembly Cloning technology followed by an amplification reaction with Phusion DNA polymerase according to the manufacturer's instructions. Amplified genes were ligated into a pENTR/D-TOPO vector (Life Technologies) using the Multisite Gateway system. Clones were transformed into One-Shot Competent Escherichia coli, and DNA was purified and sequenced. Positive clones were used for a recombination reaction with the Gateway destination vector (pcDNA-DEST40). Subsequent transformation into One-Shot Competent E. coli, followed by DNA purification and sequencing for verification of correct cloning, resulted in overexpression vectors for PAX5 and PRDM1.
Luciferase assay for enhancer activity. Enhancer sequences were generated by PCR of human genomic DNA discovered for POU5F1 and PRDM1 and then cloned into pGL4.28(luc2CP/minP/Hygro) (Promega; E8461) with restricted Data availability. All sequencing data that support the findings of this study have been deposited in NCBI's GEO under accession code GSE100639. Previously published sequencing data that were re-analysed here are available under accession codes GSE60138, GSE39821 and GSE67259. Source data for the following figures are provided in Supplementary Table 2 : Fig. 3g,h; Fig. 4a,d ,e,g,h; Fig. 5d,e,g,h,I ; Fig. 6a-c; Supplementary Fig. 2b; Supplementary Fig. 3a,d,f;  Supplementary Fig. 4c,d; Supplementary Fig. 6a,b; and Supplementary  Fig. 7a,c,d ,e,g,h. All other data supporting the findings of this study are available from the corresponding author upon reasonable request.
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Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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digested as single cells before they were subject to the flow cytometry. Mouse testis cells were dissociated with 0.25% Trypsin-EDTA for 5 min at 37 °C. Dissociated cells were passed through the 40uM strainers (BD Biosciences) and then incubated in 1% BSA in PBS containing primary antibodies on ice for 20 min. Cell population abundance Sorted cells were directly placed into DNA extraction buffer. The abundance for these samples could not be assessed.
Gating strategy
After cells were selected in the FSC/SSC dot plot to remove debris, they were gated to exclude cellular aggregates in the FSC/FSC dot plot. Gates of GFP-FITC, mOrange-PE, or CKIT-PE cells were set and compared with a control sample with no detectable fluorochrome expression.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
